Curis Lifesciences IPO – Key Details and Investment Highlights
The Curis Lifesciences IPO will open on November 7, 2025, and close on November 11, 2025. It is a Book-Built Issue IPO, through which the company aims to raise approximately ₹27.52 crores. The issue comprises a fresh issue of ₹27.52 crores and an offer for sale of [.] equity shares with a face value of ₹10 each.
The price band for the Curis Lifesciences IPO is set between ₹120 and ₹128 per share. The issue allocation is divided as follows — QIB: 50%, Retail: 35%, and HNI: 15%. The IPO allotment is expected to be finalized on November 12, 2025, and the shares are proposed to be listed on the NSE on November 14, 2025.
In terms of financial performance, the company reported a revenue of ₹49.65 crores in FY 2025, compared to ₹35.87 crores in FY 2024. Its net profit also increased to ₹6.11 crores in FY 2025 from ₹4.87 crores in FY 2024, reflecting consistent growth and profitability.
Curis Lifesciences IPO Objectives:
The net proceeds from the Curis Lifesciences IPO are proposed to be utilized for the following purposes:
- Purchase and installation of plant and machinery for Carbide Precision Tools at existing premises: ₹9.07 crores
- Funding of working capital requirements: ₹3.85 crores
- General corporate purposes: ₹2.48 crores
Curis Lifesciences IPO Review (Apply or Not)
- May Apply
Curis Lifesciences IPO Date & Price Band Details:
| IPO Open Date | November 7, 2025 |
| IPO Close Date | November 11, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹120 to ₹128 Per Share |
| Issue Size | Approx ₹27.52 Crores |
| Fresh Issue | Approx ₹27.52 Crores |
| Issue Type | Book Built Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus | Link |
| RHP Draft Prospectus | Link |
Curis Lifesciences IPO Lot Size:
The minimum market lot for the Curis Lifesciences IPO is 2,000 shares, requiring a minimum application amount of ₹2,56,000 for retail investors.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | ₹2,56,000 |
| Retail Maximum | 2 | 2,000 | ₹2,56,000 |
| S-HNI Minimum | 3 | 3,000 | ₹3,84,000 |
| S-HNI Maximum | 7 | 7,000 | ₹8,96,000 |
| B-HNI Minimum | 8 | 8,000 | ₹10,24,000 |
Curis Lifesciences IPO Allotment & Listing Date (Details)
The Curis Lifesciences IPO will open on November 7, 2025, and close on November 11, 2025. The IPO allotment is expected to be finalized on November 12, 2025, and the shares are scheduled to be listed on the NSE on November 14, 2025.
| IPO Open Date: | November 7, 2025 |
| IPO Close Date: | November 11, 2025 |
| Basis of Allotment: | November 12, 2025 |
| Refunds: | November 13, 2025 |
| Credit to Demat Account: | November 13, 2025 |
| IPO Listing Date: | November 14, 2025 |
| IPO Bidding Cut-off Time: | November 11, 2025 – 5 PM |
Curis Lifesciences IPO GMP Today:
- Update Soon
Promoters of Curis Lifesciences IPO
The promoters of Curis Lifesciences Limited are Mr. Dharmesh Dashrathbhai Patel, Mr. Siddhant Jayantibhai Pawasia, Mr. Piyush Gordhanbhai Antala, and Mr. Jaimik Mansukhbhai Patel.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 59,34,434 | 92.68% |
| Promoter Holding Post Issue | 80,84,434 | 68.03% |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Sotac Pharmaceuticals Limited | 4.32 | 18.30 | 9.00% | 47.99 | 64.76 Cr. |
| Lincoln Pharmaceuticals Limited | 41.11 | 12.21 | 12.27% | 335.34 | 645.71 Cr. |
Curis Lifesciences IPO– Company Financial Performance
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹10.46 | ₹10.56 | ₹0.08 | ₹16.83 |
| 2024 | ₹10.60 | ₹8.49 | ₹1.58 | ₹15.05 |
| 2025 | ₹14.77 | ₹10.69 | ₹2.93 | ₹19.64 |
| July 2025 | ₹5.42 | ₹3.46 | ₹1.47 | ₹22.51 |
Curis Lifesciences IPO – FY2025
| KPI | Values |
| ROE: | 55.25% |
| ROCE: | 27.83% |
| EBITDA Margin: | 19.41% |
| PAT Margin: | 12.43% |
| Debt to equity ratio: | 0.96 |
| Earning Per Share (EPS): | ₹10.29 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 37.62% |
| Net Asset Value (NAV): | ₹27.34 |
Curis Lifesciences IPO Registrar
Maashitla Securities Pvt.Ltd.
Phone: +91-11-45121795-96
Email: shining.ipo@accuratesecurities.com
Website: https://maashitla.com/allotment-status/public-issues
Curis Lifesciences IPO Lead Managers aka Merchant Bankers
Sobhagya Capital Options Pvt. Ltd.
Curis Lifesciences IPO Company Address
Shining Tools Ltd.
Survey no. 63/2, Plot No. 2,
Rajkot, Gondal Highway
paliya, ,
Gondal, Gujarat, 360311
Phone: +91 9687693344
Email: cs@tixnatools.com
Website: https://www.tixnatools.com/
Curis Lifesciences IPO FAQs
Q1. What is the Curis Lifesciences IPO?
Curis Lifesciences IPO is a Book Built Issue worth approximately ₹27.52 crores. It includes a fresh issue of ₹27.52 crores and an offer for sale of [.] equity shares.
Q2. What are the Curis Lifesciences IPO dates?
The IPO will open on November 7, 2025, and close on November 11, 2025.
Q3. What is the price band for the Curis Lifesciences IPO?
The price band is fixed at ₹120 to ₹128 per share.
Q4. What is the minimum and maximum lot size for the Curis Lifesciences IPO?
The minimum market lot is 2,000 shares, requiring an application amount of ₹2,56,000. Retail investors can apply for one lot only.
Q5. When will the Curis Lifesciences IPO allotment be finalized?
The allotment date is expected to be November 12, 2025.
Q6. When is the Curis Lifesciences IPO listing date?
The IPO shares are likely to be listed on the NSE on November 14, 2025.
Q7. Who are the promoters of Curis Lifesciences Limited?
The promoters of the company are Mr. Dharmesh Dashrathbhai Patel, Mr. Siddhant Jayantibhai Pawasia, Mr. Piyush Gordhanbhai Antala, and Mr. Jaimik Mansukhbhai Patel.
Q8. What is the Curis Lifesciences IPO GMP today?
The Curis Lifesciences IPO GMP (Grey Market Premium) will be updated daily on our website once the IPO opens. You can check the latest GMP here.
Q9. How can I check the Curis Lifesciences IPO allotment status?
You can check the IPO allotment status on the registrar’s website or through our IPO allotment status page on upcomingipowatch.in.
Q10. Is it good to invest in Curis Lifesciences IPO?
Based on the company’s consistent revenue and profit growth, the Curis Lifesciences IPO appears to be a promising investment opportunity for investors with a long-term outlook.
